Health Care Rounds

Several weeks ago we reported on Capital Rx, a new PBM with a “clearinghouse model” designed to eliminate spread pricing and price variability — and promote greater transparency. This week, John sits down with A.J. Loiacono, a veteran entrepreneur and CEO of Capital Rx. Listen in and learn about what’s wrong with pharmaceutical pricing and how A.J. intends to fix it.Speaker BiosA.J. Loiacono, CEO, Capital RxA.J. is a successful entrepreneur, with 20 years of experience in pharmacy benefits and software development. As the CEO of Capital Rx, his mission is to change the way pharmacy benefits are priced and administrated in the US. Prior to Capital Rx, A.J. was a co-founder of Truveris, where he served for eight years as CEO, Chief Innovation Officer, and Board Member, leading the company to record growth (Deloitte FAST 500 and Crain’s Fast50). Prior to Truveris, A.J. co-founded SMS Partners, a joint venture with Realogy (RLGY), and in 2010 exited the partnership with a buyout. In his first venture, A.J. starte